ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 33123732

CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013-2017.

Ostrom QT and 5 others. Neuro Oncol, 2020. Cited by 1,535 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013-2017. Papers, record 33123732. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33123732

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013-2017.
PubMed
Journal
Neuro Oncol
PubMed
Year
2020
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1,535
iCite
Relative citation ratio, by iCite
84.8
iCite
Revised in PubMed
2022-07-01
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ostrom QTQuinn T
2Patil NNirav
3Cioffi GGino
4Waite KKristin
5Kruchko CCarol
6Barnholtz-Sloan JSJill S

Source PubMed

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Brain NeoplasmsMajor topic
Central Nervous System NeoplasmsMajor topic
RegistriesMajor topic
Adolescent
Adult
Aged
Child
Child, Preschool
Female
Humans
Incidence
Infant
Infant, Newborn
Male
Middle Aged
United States
Young Adult

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials2

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT06492486Glioma Adaptive Radiotherapy With Development of an Artificial Intelligence WorkflowBackgroundClinicalTrials.gov
NCT07243470Combination of Tarlatamab and Temozolomide in Patients With Central Nervous System TumorsResultsClinicalTrials.gov

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Erratum in33,340,329Corrigendum to: CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013-2017.https://conductscience.org/library/papers/33340329

Source PubMed

References78

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
120,399,149Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma.Cancer Cell2010https://conductscience.org/library/papers/20399149PubMed
215,712,273International Classification of Childhood Cancer, third edition.Cancer2005https://conductscience.org/library/papers/15712273PubMed
322,358,457Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas.Acta Neuropathol2012https://conductscience.org/library/papers/22358457PubMed
429,931,168Adult Glioma Incidence and Survival by Race or Ethnicity in the United States From 2000 to 2014.JAMA Oncol2018https://conductscience.org/library/papers/29931168PubMed
520,821,343Epidemiology and etiology of meningioma.J Neurooncol2010https://conductscience.org/library/papers/20821343PubMed
629,315,108Review of molecular classification and treatment implications of pediatric brain tumors.Curr Opin Pediatr2018https://conductscience.org/library/papers/29315108PubMed
717,827,463Chemoradiotherapy in malignant glioma: standard of care and future directions.J Clin Oncol2007https://conductscience.org/library/papers/17827463PubMed
822,952,197Ionizing radiation and the risk of brain and central nervous system tumors: a systematic review.Neuro Oncol2012https://conductscience.org/library/papers/22952197PubMed
912,800,203Familial brain tumours-genetics or environment? A nationwide cohort study of cancer risk in spouses and first-degree relatives of brain tumour patients.Int J Cancer2003https://conductscience.org/library/papers/12800203PubMed
1025,304,271CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011.Neuro Oncol2014https://conductscience.org/library/papers/25304271PubMed

1 to 10 of 78

See all 78 references

Cited by1,198

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,535 citations.

PMIDTitleJournalYearIn PapersSource
42,938,937Optic Nerve Sheath Meningiomas: A Narrative Review of Clinical Features, Imaging Advances, and Current Management.Cancers (Basel)2026https://conductscience.org/library/papers/42938937PubMed
42,928,835Filamin A Promotes Malignant Progression and Poor Prognosis in Glioma by Regulating EMT-Related Signaling Pathways.Iran J Biotechnol2026https://conductscience.org/library/papers/42928835PubMed
42,883,932Somatostatin Receptor Expression and Theranostic Applications Across Non-Neuroendocrine Tumors: A Molecular-to-Clinical Review.Int J Mol Sci2026https://conductscience.org/library/papers/42883932PubMed
42,865,590Selinexor enhances temozolomide efficacy in glioblastoma through modulation of multiple resistance-associated mechanisms.Front Oncol2026https://conductscience.org/library/papers/42865590PubMed
42,857,743Gallium maltolate causes genomic instability to enhance glioblastoma response to radiation and temozolomide.Neurooncol Adv2026https://conductscience.org/library/papers/42857743PubMed
42,850,359The potential role of miR-34a and miR-34c in the regulation of pediatric high-grade glioma 4 aggressiveness.Pediatr Res2026https://conductscience.org/library/papers/42850359PubMed
42,812,018Meningiomas in Elderly Patients: Epidemiology, Clinical Characteristics, Prognostic Factors, and Personalized Treatment Strategies.Rev Neurol2026https://conductscience.org/library/papers/42812018PubMed
42,809,388Phosphoproteomic dysregulation promotes tumor proliferation in Cushing's disease.Proc Natl Acad Sci U S A2026https://conductscience.org/library/papers/42809388PubMed
42,802,146Pan-Cancer Analysis of the Immunomodulatory Roles and Prognostic Value of PDXP and Experimental Verification in SKCM.Cancer Med2026https://conductscience.org/library/papers/42802146PubMed
42,794,872Prognostic Value of Subependymal Enhancement on Baseline MRI in Primary Central Nervous System Lymphoma.Cancers (Basel)2026https://conductscience.org/library/papers/42794872PubMed

1 to 10 of 1,198

See all 1,198 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs2

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targetsSource
TARLATAMABCHEMBL5095292Results1https://conductscience.org/library/drugs/CHEMBL5095292ChEMBL
TEMOZOLOMIDECHEMBL810Results1https://conductscience.org/library/drugs/CHEMBL810ChEMBL

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33123732

GET https://conductscience.org/api/papers/v1/33123732/references?page=2

API referenceFor AI assistants